KOSDAQ-Listed Union Korea Pharm Issues Paid-In Capital Increase... Third-Party Allotment to Bukwang Pharmaceutical
Union Korea Pharm, a KOSDAQ-listed company, announced on the 18th that it has decided to issue new shares through a third-party allotment paid-in capital increase.
Hot Picks Today
"Why Are There So Many Female Students?" Jensen Huang Surprised During First Visit to Seoul National University in 18 Years
- [Exclusive] Chinese Woman Posing as Wife of Korean Conglomerate Employee Defrauds Acquaintances Out of Billions as 'Two-Faced Investor'
- "I'll Put in All My Money" "Like Winning the Lottery": 457 Trillion Won Pours In... The Global Investment Craze Shakes the World [SpaceX Investment Analysis]
- "This Place Is Crazy, Four Somaek Shots as Soon as I Arrived" "I Feel Like I'm Going to Die"... KakaoTalk Messages Left by Deceased Female Firefighter in Her 20s
- [Breaking] Hwang Inbeom and Oh Hyunkyoo Score as Hong Myungbo's Squad Secures Thrilling 2-1 Come-from-Behind Victory over Czech Republic
A total of 60 million new common shares will be issued at 500 won per share. The third-party allotment recipient is Bukwang Pharmaceutical Co., Ltd. (60 million shares).
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
